Yüklüyor......
Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?
Our knowledge of the pathophysiology of affect dysregulation has progressively increased, but the pharmacological treatments remain inadequate. Here, we summarize the current literature on deficits in somatostatin, an inhibitory modulatory neuropeptide, in major depression and other neurological dis...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3766825/ https://ncbi.nlm.nih.gov/pubmed/24058344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2013.00110 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|